Patent · US Active

Bicyclic hydroxamic acids useful as inhibitors of mammalian histone deacetylase activity

US10654814B2 · kind B2 · utility

2Cited by

0References

16Claims

0Family size

Assignee

Kancera AB · SE

Inventors

Kristin Hammer · Sollentuna, SE
Mattias Jonsson · Uppsala, SE
Lars Krüger · Huddinge, SE

Key dates

Filing date	Nov 16, 2016
Grant date	May 19, 2020
Priority date	—
Expiry date	Nov 16, 2036

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K31/57
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A compound of formula (Ia) or (Ib) or a pharmaceutically acceptable salt thereof. The compound is an inhibitor of a histone deacetylase, and as such is useful in therapy, e.g. in the treatment of autoimmune disorders, mental disorders, neurodegenerative disorders, and hyperproliferative disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.